Dr Charlotte Lemech is a Medical Director and Medical Oncologist at University of New South Wales, Sydney, AU. She works in Scientia Clinical Research (SCR), the first publicly funded purpose-built early phase clinical trials centre in UNSW.
Dr Lemech conducts first-in-human and first-in-patient studies in cancer and across other disciplines, both for novel therapies as well as methods of disease diagnosis and detection. After completing her FRACP in medical oncology in the SESIAHS network, Dr Lemech worked for 4 years in London at an early phase clinical trials unit, Sarah Cannon Research UK, and completed a MD(res) at University College London.
She has experience in managing phase I-III clinical trials across a spectrum of tumour streams and molecular targets including immunotherapy, PI3K/Akt, RAF/MEK, FAK, FGFR and others.
